Effect of BET inhibition on CV outcomes in ACS and diabetes patients
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program credits
Prof. Kausik Ray
- MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
0.75 credits 4 episodesProf. Kausik Ray, MBChB, MD, MPhil
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
John Kastelein, MD, PhD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Prof. Alberto Zambon MD, PhD, FAHA
Prof. Kausik Ray, MBChB, MD, MPhil
Azfar Zaman, MD
